Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tubulin-folding cofactor D is a chaperone protein involved in the cytosolic folding and assembly of β-tubulin, which is required to build functional microtubules, a key component of the cytoskeleton[1][2][3][4]. TBCD captures and stabilizes β-tubulin intermediates in a near-native state, enabling their proper incorporation into α/β-tubulin heterodimers, with further action by cofactors C and E[1][2][4]. TBCD also functions as a centrosomal protein, necessary for the recruitment of the γ-tubulin ring complex at the centrosome and microtubule nucleation[2][3]. Mutations in the TBCD gene cause rare, often severe, neurodevelopmental and neurodegenerative disorders, characterized by microcephaly, developmental delay, epilepsy, and hypotonia[2]. TBCD forms a regulatory complex with ARL2 and β-tubulin, crucial for microtubule assembly in neural and other cell types[2]. There are currently no direct drug interactions or established targeted therapies for TBCD, and it is not widely considered a classic therapeutic target, such as a receptor or enzyme[1][2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tubulin-folding cofactor D (TBCD).